40 Results

People

  1. Panageas
    Panageas
  2. Coit
    Coit
  3. Brady
    Brady
  4. Chapman
    Chapman
  5. Wolchok
    Wolchok
  6. Hudis
    Hudis
  7. Norton
    Norton
  8. Busam
    Busam
  9. De Angelis
    De Angelis
  10. Tan
    Tan

Groups

  1. Biostatistics Service (40)
  2. Epidemiology and Biostatistics (40)
  3. Population Sciences Research Program (40)
  4. Department of Medicine (21)
  5. Solid Tumor Oncology Division (20)
  6. Survivorship Research (20)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (17)
  8. Melanoma Disease Management Team (14)
  9. Surgery (14)
  10. GSK Faculty (13)
  1. "human tissue"
  2. "Katherine Panageas"
Formats
  1. Journal Article (40)
Groups
  1. Biostatistics Service (40)
  2. Epidemiology and Biostatistics (40)
  3. Population Sciences Research Program (40)
  4. Department of Medicine (21)
  5. Solid Tumor Oncology Division (20)
  6. Survivorship Research (20)

More Groups

People
  1. Katherine Panageas (40)
  2. Paul Chapman (10)
  3. Daniel Coit (9)
  4. Jedd Wolchok (8)
  5. Mary Brady (8)
  6. Clifford Hudis (6)

More People

Years
  1. 2023 (2)
  2. 2021 (1)
  3. 2020 (1)
  4. 2018 (1)
  5. 2017 (2)
  6. 2015 (1)

More Years

Publications
  1. Annals of Surgical Oncology (6)
  2. Cancer (5)
  3. Clinical Cancer Research (4)
  4. Journal of Clinical Oncology (4)
  5. Annals of Oncology (2)
  6. Journal of Neuro-Oncology (2)

More Publications

Publishers
  1. Springer (8)
  2. Wiley Blackwell (6)
  3. American Association for Cancer Research (5)
  4. American Society of Clinical Oncology (5)
  5. Oxford University Press (4)
  6. Cell Press (2)

More Publishers

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integration of peripheral blood- and tissue-based biomarkers of response to immune checkpoint blockade in urothelial carcinoma
    Journal Article

    Vanguri, R. S.; Smithy, J. W.; Li, Y.; Zhuang, M.; Maher, C. A.; Aleynick, N.; Peng, X.; Al-Ahmadie, H.; Funt, S. A.; Rosenberg, J. E.; more...
    Journal of Pathology (2023)

    Fulltext@MSK | Save
  • T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
    Journal Article

    Hirschhorn, D.; Budhu, S.; Kraehenbuehl, L.; Gigoux, M.; Schröder, D.; Chow, A.; Ricca, J. M.; Gasmi, B.; De Henau, O.; Mangarin, L. M. B.; more...
    Cell (2023)

    Fulltext@MSK | Save
  • Durable 5-year local control for resected brain metastases with early adjuvant SRS: The effect of timing on intended-field control
    Journal Article

    Bander, E. D.; Yuan, M.; Reiner, A. S.; Panageas, K. S.; Ballangrud, Å M.; Brennan, C. W.; Beal, K.; Tabar, V.; Moss, N. S.
    Neuro-Oncology Practice (2021)

    Fulltext@MSK | Save
  • Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival
    Journal Article

    Schaff, L. R.; Yan, D.; Thyparambil, S.; Tian, Y.; Cecchi, F.; Rosenblum, M.; Reiner, A. S.; Panageas, K. S.; Hembrough, T.; Lin, A. L.
    Journal of Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma
    Journal Article

    Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Radiotherapy and temozolomide for anaplastic astrocytic gliomas
    Journal Article

    Nayak, L.; Panageas, K. S.; Reiner, A. S.; Huse, J. T.; Pentsova, E.; Braunthal, S. G.; Abrey, L. E.; Deangelis, L. M.; Lassman, A. B.
    Journal of Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin
    Journal Article

    Melstrom, L. G.; Taylor, E.; Kuk, D.; Frankel, T. L.; Panageas, K.; Haydu, L.; Sabel, M. S.; Thompson, J. F.; Ariyan, C.; Coit, D. G.; more...
    Annals of Surgical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma
    Journal Article

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save